查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612968

西拉普利市场：按配方、形式、应用、分销管道划分 - 2025-2030 年全球预测

Cilazapril Market by Formulation (Cilazapril Hydrochloride, Cilazapril Monohydrate), Form (Capsules, Tablets), Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年西拉普利市值为2.4002亿美元，预计2024年将达到2.5157亿美元，复合年增长率为5.07%，预计到2030年将达到3.3938亿美元。

西拉普利是血管收缩素转化酵素(ACE) 抑制剂，主要用于治疗高血压和心臟衰竭。随着全世界心血管疾病的增加，对西拉普利等有效治疗方法的需求不断增加。其用途包括控制高血压、降低中风和心肌梗塞的风险、协助治疗心臟衰竭，进而提高患者的存活率和生活品质。最终用途包括医院、诊所和居家医疗场所，医生单独制定它或与其他治疗方法结合使用。由于越来越多的老年人更容易患心血管疾病，对西拉普利等有效抗高血压药物的组合和需求不断增加，影响了市场成长。由于医疗保健和意识的改善，新兴市场提供了巨大的商机。药物组合和新的给药方法等创新可以提高疗效和患者依从性，从而提供利润丰厚的成长途径。然而，ACE 抑制剂与咳嗽和高血钾等副作用有关，这可能会限制其使用。此外，来自血管收缩素II 受体阻断剂 (ARB) 等替代药物类别的竞争也是一个挑战。学名药的流行也影响品牌药的市场占有率和盈利。为了缓解这些挑战，公司可以投资研究新适应症和改进的输送系统。此外，透过进入亚太和拉丁美洲不断增长的市场，我们将能够开拓并推动心血管疾病日益流行但诊断不足的市场的成长。在这些地区实施教育倡议以提高诊断和治疗依从性可以扩大基本客群。总体而言，该市场竞争适中，具有巨大的创新和成长空间，特别是透过饱和度较低的地理细分市场以及治疗应用和输送机制的多样化。

主要市场统计
基准年[2023] 24002万美元
预计年份 [2024] 25157万美元
预测年份 [2030] 33938万美元
复合年增长率（%） 5.07%

市场动态：揭示快速发展的西拉普利市场的关键市场洞察

供需的动态交互作用正在改变西拉普利市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 高血压和心臟病的盛行率增加
    • 各国老年人口数量增加
  • 市场限制因素
    • 与西拉普利相关的产品召回和副作用
  • 市场机会
    • 加强医疗资金筹措和基础建设
    • 联合治疗以增强药物疗效
  • 市场问题
    • 替代治疗的可用性

波特的五力：驾驭西拉普利市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解西拉普利市场的外部影响

外部宏观环境因素在塑造西拉普利市场的业绩动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解西拉普利市场的竞争格局

对西拉普利市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：西拉普利市场供应商绩效评估

FPNV定位矩阵是评估西拉普利市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製西拉普利市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，西拉普利市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 高血压和心臟病的发生率增加
      • 各国人口老化进展
    • 抑制因素
      • 与西拉普利相关的产品召回和副作用
    • 机会
      • 增加医疗保健方面的资金和改善基础设施
      • 联合治疗以增强药物疗效
    • 任务
      • 替代治疗方法的可用性
  • 市场区隔分析
    • 配方：经常使用盐酸西拉普利以增加药物溶解度和稳定性
    • 用途：扩大西拉普利药物的服用量，以降低高血压、预防心臟病和肾臟问题
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 西拉普利市场：依配方分类

  • 介绍
  • 盐酸西拉普利
  • 西拉普利一水化合物

第七章 西拉普利市场：依形式

  • 介绍
  • 胶囊
  • 锭剂

第八章西拉普利市场：依应用分类

  • 介绍
  • 心臟衰竭管理
  • 高血压管理

第九章西拉普利市场：按分销管道

  • 介绍
  • 医院药房
  • 线下零售药局
  • 网路药房

第十章 西拉普利美洲市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太西拉普利市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 西拉普利欧洲、中东和非洲市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Lupin 获得美国FDA核准西拉普利非专利
  • 战略分析和建议

公司名单

  • Adooq Bioscience LLC
  • ANGLE BIO PHARMA
  • ApexBio Technology
  • Biorbyt Ltd.
  • Biosynth Ltd.
  • Cayman Chemical
  • Chemicea Limited
  • Enomark
  • He Ako Hiringa
  • Hetero Labs Limited
  • LGM Pharma
  • Manus Aktteva Biopharma LLP
  • Merck KGaA
  • MIMS Pte Ltd.
  • Santa Cruz BIoTechnology, Inc.
Product Code: MRR-7949F05838FE

The Cilazapril Market was valued at USD 240.02 million in 2023, expected to reach USD 251.57 million in 2024, and is projected to grow at a CAGR of 5.07%, to USD 339.38 million by 2030.

Cilazapril is an angiotensin-converting enzyme (ACE) inhibitor primarily used for managing hypertension and heart failure. As the presence of cardiovascular diseases rises globally, the necessity for effective treatments like Cilazapril grows. Its application spans controlling high blood pressure, reducing the risk of strokes and myocardial infarction, and aiding in the management of heart failure, thereby improving patient survival and quality of life. End-use scope includes hospitals, clinics, and home care settings, wherein physicians prescribe it singularly or in combination with other therapeutic regimens. Market growth is influenced by the rising geriatric population susceptible to cardiovascular ailments, leading to increased prescription and demand for effective antihypertensive medications like Cilazapril. Emerging markets are offering vast opportunities due to increasing healthcare access and awareness. Innovations such as combination drugs or new delivery methodologies could enhance efficacy or patient compliance, providing lucrative growth avenues. However, the market faces limitations from side effects associated with ACE inhibitors, like cough and hyperkalemia, which may restrain usage. Furthermore, competition from alternative drug classes like angiotensin II receptor blockers (ARBs) presents challenges. Generic drug penetration also impacts market share and profitability for branded versions. To mitigate these challenges, firms can invest in research for Cilazapril's possible new indications or improved delivery systems. Additionally, tapping into growing markets in Asia-Pacific and Latin America, where cardiovascular diseases are increasingly prevalent but underdiagnosed, could drive growth. Conducting educational initiatives to increase diagnosis and treatment compliance in those regions might expand the customer base. Overall, the market is moderately competitive with significant room for innovation and growth, particularly in less saturated geographic sectors and through diversification of treatment applications and delivery mechanisms.

KEY MARKET STATISTICS
Base Year [2023] USD 240.02 million
Estimated Year [2024] USD 251.57 million
Forecast Year [2030] USD 339.38 million
CAGR (%) 5.07%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cilazapril Market

The Cilazapril Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of hypertension and heart conditions
    • Growing geriatric population across countries
  • Market Restraints
    • Product recall and side effects associated with cilazapril
  • Market Opportunities
    • Enhanced funding and infrastructure improvements in healthcare
    • Combination therapies to enhance drug efficacy
  • Market Challenges
    • Availability of alternative treatments

Porter's Five Forces: A Strategic Tool for Navigating the Cilazapril Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cilazapril Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cilazapril Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cilazapril Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cilazapril Market

A detailed market share analysis in the Cilazapril Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cilazapril Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cilazapril Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cilazapril Market

A strategic analysis of the Cilazapril Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cilazapril Market, highlighting leading vendors and their innovative profiles. These include Adooq Bioscience LLC, ANGLE BIO PHARMA, ApexBio Technology, Biorbyt Ltd., Biosynth Ltd., Cayman Chemical, Chemicea Limited, Enomark, He Ako Hiringa, Hetero Labs Limited, LGM Pharma, Manus Aktteva Biopharma LLP, Merck KGaA, MIMS Pte Ltd., and Santa Cruz Biotechnology, Inc..

Market Segmentation & Coverage

This research report categorizes the Cilazapril Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Formulation, market is studied across Cilazapril Hydrochloride and Cilazapril Monohydrate.
  • Based on Form, market is studied across Capsules and Tablets.
  • Based on Application, market is studied across Heart Failure Management and Hypertension Management.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Offline Retail Pharmacies, and Online Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of hypertension and heart conditions
      • 5.1.1.2. Growing geriatric population across countries
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall and side effects associated with cilazapril
    • 5.1.3. Opportunities
      • 5.1.3.1. Enhanced funding and infrastructure improvements in healthcare
      • 5.1.3.2. Combination therapies to enhance drug efficacy
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative treatments
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Formulation: Extensive usage of cilazapril hydrochloride formulation to enhance medication's solubility and stability
    • 5.2.2. Application: Expanding consumption of cilazapril drugs to lower high blood pressure, prevent heart attacks, and kidney problems
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cilazapril Market, by Formulation

  • 6.1. Introduction
  • 6.2. Cilazapril Hydrochloride
  • 6.3. Cilazapril Monohydrate

7. Cilazapril Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Tablets

8. Cilazapril Market, by Application

  • 8.1. Introduction
  • 8.2. Heart Failure Management
  • 8.3. Hypertension Management

9. Cilazapril Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Offline Retail Pharmacies
  • 9.4. Online Pharmacies

10. Americas Cilazapril Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cilazapril Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cilazapril Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Lupin Secures USFDA Approval for Generic Cilazapril
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adooq Bioscience LLC
  • 2. ANGLE BIO PHARMA
  • 3. ApexBio Technology
  • 4. Biorbyt Ltd.
  • 5. Biosynth Ltd.
  • 6. Cayman Chemical
  • 7. Chemicea Limited
  • 8. Enomark
  • 9. He Ako Hiringa
  • 10. Hetero Labs Limited
  • 11. LGM Pharma
  • 12. Manus Aktteva Biopharma LLP
  • 13. Merck KGaA
  • 14. MIMS Pte Ltd.
  • 15. Santa Cruz Biotechnology, Inc.

LIST OF FIGURES

  • FIGURE 1. CILAZAPRIL MARKET RESEARCH PROCESS
  • FIGURE 2. CILAZAPRIL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CILAZAPRIL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CILAZAPRIL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CILAZAPRIL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CILAZAPRIL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CILAZAPRIL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CILAZAPRIL MARKET DYNAMICS
  • TABLE 7. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL MONOHYDRATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CILAZAPRIL MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CILAZAPRIL MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CILAZAPRIL MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CILAZAPRIL MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CILAZAPRIL MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CILAZAPRIL MARKET SIZE, BY OFFLINE RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CILAZAPRIL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. CILAZAPRIL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. CILAZAPRIL MARKET, FPNV POSITIONING MATRIX, 2023